Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’
Normally, leukemia is a disease that strikes old people and babies. So, when I was diagnosed with chronic myeloid leukemia in November 2022, I was shocked. There is zero history of cancer in my family. At the time, I was only 36.
I was even more shocked to learn that I had not just one form of leukemia, but two: chronic myeloid leukemia and acute myeloid leukemia.  ...
Astrocytoma survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
Until Groundhog Day 2018, I’d been living a healthy and normal life in Austin with my wife, Amy, and our two young children. Then one day,...
Stage IV lung cancer survivor: ‘Go straight to UT MD Anderson’
By the time I was diagnosed with stage IV lung cancer in the fall of 2024, it had spread all ...
How an electrical engineer is making a big impact on cancer research
Xiling Shen, Ph.D., was an electrical engineering professor when a landmark discovery prompted him to shift the focus of his work and dedicate his lab to precision medicine.
Throughout his life, Shen had felt the pull of medicine. As a high school student in Shanghai, he dreamed of becoming a doctor. But when he was in high school, he lost his uncle to colorectal cancer. Watching his uncle suffer caused Shen to fear that a career...
Can UV light really be used as a cancer treatment?
Normally, you probably hear health care professionals talk about ultraviolet (UV) light regarding sun safety.
That’s because...
15-year stage IV melanoma survivor: ‘This is the best I’ve felt in years’
Sometimes, when people receive a cancer diagnosis, they start going from one doctor to the next, hoping to hear better news.
Dermatologist: How to deal with targeted therapy-related skin rashes
EGFR inhibitors are a class of targeted therapy used to treat several cancers, including colorectal cancer.
About 80% of patients...
Top 5 MD Anderson abstracts at AACR 2025
The American Association for Cancer Research (AACR) Annual Meeting showcases exciting new cancer therapies that help link translational science...
Triple-negative breast cancer survivor: Why I chose a clinical trial at MD Anderson
Cancer runs very strongly on one side of my family. Several members have had either breast cancer or ovarian cancer. Two tested positive for...
Head of Cancer Medicine: ‘MD Anderson is the place I bring my loved ones’
As a physician-scientist, I have a series of roles at MD Anderson. I’m the division head of Cancer Medicine where I oversee 16 medical oncology...